C332C genotype of glyoxalase 1 and its association with late diabetic complications

Experimental and Clinical Endocrinology and Diabetes

Volumn 121, Issue 7, 2013, Pages 436-439

  Groener, J B ^a   Reismann, P ^a   Fleming, T ^a   Kalscheuer, H ^a   Lehnhoff, D ^a   Hamann, A ^a   Roser, P ^a   Bierhaus, A ^b   Nawroth, P P ^a   Rudofsky, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

detoxification; diabetes; diabetic neuropathy; Glo1 A332C; methylglyoxal; rs4746

Indexed keywords

GLYOXALASE; METHYLGLYOXAL; RESTRICTION ENDONUCLEASE;

ADULT; ALLELE; ARTICLE; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HOMOZYGOSITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84880071752     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0033-1345124     Document Type: Article

References (26)

1. Phillips S. A., Thornalley P. J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. Eur J Biochem: 1993; 212 101 105
2. Rabbani N., Thornalley P. J. Glyoxalase in diabetes, obesity and related disorders. Semin Cell Dev Biol 22 309 317
3. Chen F., Wollmer M. A., Hoerndli F. et al. Role for glyoxalase I in Alzheimer's disease. Proc Natl Acad Sci USA: 2004; 101 7687 7692 (Pubitemid 38658090)
4. Thornalley P. J. Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans: 2003; 31 1343 1348 (Pubitemid 38030973)
5. Bierhaus A., Nawroth P. P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia: 2009; 52 2251 2263
6. Callaghan B. C., Little A. A., Feldman E. L. et al. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev 6 CD007543
7. Bierhaus A., Fleming T., Stoyanov S. et al. Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. Nature medicine: 2012; 18 926 33 [Epub 2012/05/15]
8. Jack M. M., Ryals J. M., Wright D. E. Protection from diabetes-induced peripheral sensory neuropathy - a role for elevated glyoxalase I? Exp Neurol 234 62 69
9. Engelen L., Ferreira I., Brouwers O. et al. Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies. J Hypertens: 2009; 27 1399 1403
10. Junaid M. A., Kowal D., Barua M. et al. Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am J Med Genet A.: 2004; 131 11 17 (Pubitemid 39434789)
11. Cameron A. D., Olin B., Ridderstrom M. et al. Crystal structure of human glyoxalase I - evidence for gene duplication and 3D domain swapping. Embo J: 1997; 16 3386 3395 (Pubitemid 27250034)
12. Degaffe G. H., Vander Jagt D. L., Bobelu A. et al. Distribution of glyoxalase I polymorphism among Zuni Indians: the Zuni Kidney Project. J Diabetes Complications: 2008; 22 267 272 [Epub 2008/04/17] (Pubitemid 351885490)
13. Ranganathan S., Ciaccio P. J., Walsh E. S. et al. Genomic sequence of human glyoxalase-I: analysis of promoter activity and its regulation. Gene: 1999; 240 149 155 [Epub 1999/11/24] (Pubitemid 29516442)
14. Turk Z., Cavlovic-Naglic M., Turk N. Relationship of methylglyoxal-adduct biogenesis to LDL and triglyceride levels in diabetics. Life Sci 89 485 490
15. Jarmuzewska E. A., Ghidoni A., Mangoni A. A. Hypertension and sensorimotor peripheral neuropathy in type 2 diabetes. Eur Neurol: 2007; 57 91 95
16. Keech A., Simes R. J., Barter P. et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet: 2005; 366 1849 1861
17. Shepherd J. Dyslipidaemia in diabetic patients: time for a rethink. Diabetes Obes Metab: 2007; 9 609 616 (Pubitemid 47261843)
18. Sidoti A., Antognelli C., Rinaldi C. et al. Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms: susceptibility factors of multiple sclerosis? Mult Scler: 2007; 13 446 453 (Pubitemid 46796504)
19. Kalousova M., Jachymova M., Germanova A. et al. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients. Kidney Blood Press Res 33 30 36
20. Samadi A. A., Fullerton S. A., Tortorelis D. G. et al. Glyoxalase I phenotype as a potential risk factor for prostate carcinoma. Urology: 2001; 57 183 187 (Pubitemid 32065853)
21. Barua M., Jenkins E. C., Chen W. et al. Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity - implications for autism. Autism Res 4 262 270
22. Rath J., Gowri V. S., Chauhan S. C. et al. A glutathione-specific aldose reductase of Leishmania donovani and its potential implications for methylglyoxal detoxification pathway. Gene: 2009; 429 1 9
23. Koizumi K., Nakayama M., Zhu W. J. et al. Characteristic effects of methylglyoxal and its degraded product formate on viability of human histiocytes: a possible detoxification pathway of methylglyoxal. Biochem Biophys Res Commun 407 426 431
24. Peculis R., Konrade I., Skapare E. et al. Identification of glyoxalase 1 polymorphisms associated with enzyme activity. Gene: 2013; 515 140 143 [Epub 2012/12/04]
25. Rodriguez S., Gaunt T. R. Day INM. Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies. American Journal of Epidemiology: 2009; Advance Access published on January 6, 2009 10.1093/aje/kwn359
26. Senthilkumar K., Thirumurugan R. Impact of tobacco on glutathione s transferase gene Loci of Indian ethnics. Asian Pac J Cancer Prev: 2012; 13 5037 5042